AAA | Action Against Age-related macular degeneration

AAAMD Executive Officer Team has taken voluntary pay cut in response to COVID-19

Effective April 1st, the AAAMD Executive Officer Team will take a voluntary 30% pay cut. The AAAMD Team continues to work in full from home and stands in solidarity with the charitable sector and UK Society during this unprecedented time.

Action Against Age-related

Macular Degeneration

Age-related macular degeneration (AMD) is one of the leading causes of blindness in the world. Around 10 million people have late-stage AMD globally. It is the most common cause of sight loss in the developed world. In the UK alone there are more than 685,000 people with significant sight loss as a consequence of late-stage AMD. With world populations ageing, AMD cases are expected to double by 2040.

Action Against AMD is a groundbreaking initiative determined to stop this sight loss epidemic.

We are structured as a medical research charity focused on facilitating research around early-stage AMD, raising awareness and funding from strategic organisations around the world.

Our Founders

Action Against AMD was founded by four leading sight loss charities to join efforts in identifying new interventions to stop the progression of early AMD.

Blind Veterans UK, Fight for Sight, the Macular Society and Scottish War Blinded continue to operate as independent charities alongside Action Against AMD.

Our Mission

Our mission is to find and enable convenient, affordable and accessible solutions to stop AMD in its early stages, before it causes sight loss.

An estimated 196 million people in the world live with AMD, a figure that will increase to 288 million by 2040. Around 10 million people have significant sight loss due to AMD, and that number is expected to rise to 20 million by 2040.